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Pulmonary edema worsens the morbidity and increases the mortality of critically ill patients. Mechanistically, edema formation in
the lung is a result of net ﬂow across the alveolar capillary membrane, dependent on the relationship of hydrostatic and oncotic
pressures.Traditionally,thecontributionofacutekidneyinjury(AKI)totheformationofpulmonaryedemahasbeenattributedto
bulkﬂuidaccumulation,increasingcapillaryhydrostaticpressureandthegradientfavoringnetﬂowintothealveolarspaces.Recent
research has revealed more subtle, and distant, eﬀects of AKI. In this review we discuss the concept of nephrogenic pulmonary
edema. Pro-inﬂammatory gene upregulation, chemokine over-expression, altered biochemical channel function, and apoptotic
dysregulation manifest in the lung are now understood as “extra-renal” and pulmonary eﬀects of AKI. AKI should be counted as
a disease process that alters the endothelial integrity of the alveolar capillary barrier and has the potential to overpower the ability
of the lung to regulate ﬂuid balance. Nephrogenic pulmonary edema, therefore, is the net eﬀect of ﬂuid accumulation in the lung
as a result of both the macroscopic and microscopic eﬀects of AKI.
1.Introduction
Pulmonary edema, a state of abnormal ﬂuid accumulation
in the alveolar space of the lung, can interfere with normal
oxygenation and ventilation. At baseline, the heart, lungs,
and vascular system work in concert to facilitate ﬂuid
movement through the capillary and lymphatic beds of
the lung ensuring adequate oxygen transport with limited
transudation of ﬂuid from the lung interstitium into the
alveolar space. In disease states causing acute lung injury
(ALI), both direct and indirect, this harmony can be
disrupted.
Pulmonary edema aﬀects the morbidity and overall mor-
talityofcriticallyillpatients.Patientswithpulmonaryedema
have longer hospital stays, duration of mechanical ventila-
tion, and rates of pneumonia in both adults and children [1–
3].Inadultandpediatricpopulations,pulmonaryedemacan
complicatethehospitalcourseofanypatient,buthasnotable
eﬀects on those with primary respiratory failure, transplant
surgery, cardiothoracic surgery, or traumatic brain inj-
ury. More recently, clinicians are appreciating the impact of
acute kidney injury (AKI) on ventilation and water balance
in the lung. As clinical and experimental evidence continues
to mount for organ crosstalk, the relationship between
the kidney and the lung in critical illness emerges as
pathologically signiﬁcant [4].
Thepurposeofthisbriefnarrativeistodiscussthepoten-
tial impact of AKI on lung homeostasis, speciﬁcally water
balance. Numerous laboratory models of isolated AKI have
demonstrated deleterious eﬀects on lung pathology and sup-
port the existence of kidney-lung crosstalk. Using this back-
ground, we propose the concept of nephrogenic pulmonary
edema. Though ﬂuid overload is often seen in patients with
acute renal failure, we highlight the evidence pointing to a
stateofpulmonaryedemainducedbyextrarenalmicroscopic
eﬀects of kidney injury. Timely identiﬁcation of these eﬀects
of AKI may aid in the treatment of this disease process which
has signiﬁcant associated morbidity and mortality [5].2 Pulmonary Medicine
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Figure 1: Nephrogenic pulmonary edema. Acute kidney injury triggers numerous mechanisms which alter the homeostasis of pulmonary
interstitial and alveolar ﬂuid balance. Qf: net ﬂow across the alveolar-capillary membrane; Kf:ﬁ l t r a t i o nc o e ﬃcient; PC: capillary hydrostatic
pressure; PT:interstitial ﬂuidhydrostatic pressure; σ:r e ﬂ ecti o nc oe ﬃcient of the alveolar-capillary membrane; πC: capillary oncotic pressure;
πT: interstitial oncotic pressure; NOS: nitric oxide synthase; HO-1: heme-oxygenase-1; Lcn-2: lipocalin-2; CXCL-2: chemokine ligand-2;
IL-6: interleukin-6; TNF-α: tumor necrosis factor-α; Na/K-ATPase: sodium-potassium ATPase; ENaC: endothelial sodium channel. It is
important to note that negative changes in the reﬂection coeﬃcient likely also increase the ﬁltration coeﬃcient leading to a net increase in
ﬂuid ﬂow across the alveolar-capillary membrane.
2.Pathophysiology
Pulmonary edema occurs when net ﬂow across the alveolar-
capillary membrane is positive. Under normal conditions,
ﬂuidinthealveolarspaceisdrainedbypulmonarylymphatic
vessels and then contained within the interstitial space. If the
alveolar epithelial barrier is disrupted or if the interstitial
ﬂuid volume of the lungs increases by more than 50%,
ﬂooding of the alveolar space can occur [6]. The movement
of ﬂuid is dependent on both hydrostatic and oncotic
pressures and is modeled by the Starling equation
Qf = Kf[(PC −PT) − σ(πC −πT)],( 1 )
where Qf is the net ﬂow across the alveolar-capillary
membrane; Kf is the ﬁltration coeﬃcient (dependent on
the permeability and the surface area of the membrane);
PC is the capillary hydrostatic pressure; PT is the interstitial
ﬂuid hydrostatic pressure; σ is the reﬂection coeﬃcient of
the alveolar-capillary membrane (σ = 1 if the membrane
is impermeable to protein, and σ = 0 if the membrane is
completely permeable to protein); πC is the capillary oncotic
pressure; πT is the interstitial oncotic pressure [7]. In normal
conditions, capillary hydrostatic pressure (PC) approximates
interstitial ﬂuid hydrostatic pressure (PT), (PC   PT), such
that net ﬂuid movement (Qf) is low and ﬂuid stays in the
capillary lumen. Similarly, capillary oncotic pressure (πC)i s
normally greater than interstitial oncotic pressure (πT), and
since the reﬂection coeﬃcient (σ) is generally near 1 (0.7–
0.95), Qf is generally low. Implicit in the equation is that any
force or mechanism that creates a large diﬀerence between
the hydrostatic forces and the oncotic forces will increase Qf,
and thus ﬂux of ﬂuid from the capillary bed into the alveolar
space. The lung has safety measures in place to prevent such
leakage. The lymphatic system has high capacitance and ﬂow
to clear excess ﬂuid from the interstitium. The capillary
endothelium between the interstitium and the alveolar beds
cantolerateincreasingamountsofhydrostaticandinterstitial
ﬂuid pressure [8]. However, in conditions of excess lung
water such as pulmonary edema, overall oncotic pressure
becomes dilute (thereby increasing the discrepancy between
the hydrostatic and the oncotic pressures) favoring net ﬂow
of ﬂuid into the alveolar space (Figure 1).
Aside from bulk ﬂuid and protein eﬀects, changes at
the microscopic level change permeability of the alveolar
capillary endothelium. Decreased expressions of sodium
transport molecules, such as the epithelial sodium channel
(ENaC), the sodium-potassium-ATPase pump (Na+/K+-
ATPase), or the cystic ﬁbrosis transmembrane conductance
regulator (CFTR), all contribute to increased alveolar ﬂuid
accumulation in experimental models of pulmonary edema
[9,10].ENaCpromotessodiumabsorptionfromthealveolar
space into the lung epithelial cells. Similarly, the sodium
ATPase pump allows for sodium extrusion from the alveolus.
Aberrant expression of either has signiﬁcant ramiﬁcations
for ﬂuid balance as water passively follows sodium. Addi-
tionally, the regulation of ﬂuid clearance by endogenous
catecholamines, particularly the β-adrenergic system, has
been highlighted [11].
Variations in vascular preload, capillary endothelial
integrity, and aberrations in osmotic pressure can alter the
interstitial-alveolar ﬂuid balance. Increased vascular preload
leading to pulmonary edema is commonly observed inPulmonary Medicine 3
patients with left-sided cardiogenic shock and disorders of
incomplete pulmonary vascular drainage. In these situa-
tions, the capacitance of the interstitial lymphatic system
is overwhelmed, the PC   PT, and ﬂuid spills from the
vascular space down a hydrostatic gradient. Acutely negative
intrathoracic pressure raises left ventricular stroke work and
likely leads to backup of ﬂuid into the pulmonary bed
(increasing PC) in postobstructive pulmonary edema. The
integrity of the alveolar capillary endothelium is altered
in acute respiratory distress syndrome (ARDS), sepsis,
and stress states [12, 13]. Bacterial contribution to type
II pneumocyte surfactant production has been linked to
increased capillary permeability in sepsis [14]. Such disease
statesalterthereﬂectioncoeﬃcient(σ),decreasingtheability
of oncotic pressure to balance hydrostatic pressure in the
Starlingequation.Neurogenicpulmonaryedema,commonly
observed in intracranial hypertension, may both alter the
sympathetic catecholamine regulation of the systemic circu-
lation, thereby diverting blood to the alveolar capillary bed
(↑ PC), and disrupt capillary integrity [15]. Finally, acute
or chronic disease states commonly carry the comorbidity
of hypoproteinemia. Low circulating serum total protein
levels directly reduce the capillary oncotic pressure, favoring
ﬂuid eﬄux from the luminal space. The interstitial-alveolar
interface in the lung is under tight control and can be
aﬀected by disease states that cause dysregulation in total
body ﬂuid status, levels of inﬂammatory mediators, and
aberrant protein homeostasis.
3.AKI andFluidBalance
Acute kidney injury complicates critical illness in many
ways. Concomitant with the diagnosis of AKI was ﬂuid
overload, which has been found retrospectively to indepen-
dently increase morbidities such as duration of mechanical
ventilation and hospital length of stay, and overall mortality
[16–18].Fluidoverloadcarriesincreasedriskofmorbidityin
mortality in both adults and children [19]. On retrospective
review, children with greater degrees of ﬂuid overload had
higher mortality on initiation of renal replacement therapy
[20].
The kidney is central to many homeostatic mechanisms
in the body, and as AKI progresses dysregulation occurs in
various locations in the body. The kidney communicates
with the lung in several ways: regulating acid-base balance,
increasing oxygen carrying capacity through erythropoiesis,
and regulating blood pressure through the renin-angioten-
sin-aldosterone axis. All of these processes may be altered in
AKI. The deleterious connection between the kidney and the
lung in disease states, ﬁrst reported by Bass and Singer in
1950, was assumed to be secondary to uremia and ﬂuid over-
load[21]. However, despite the use of dialysis to limit uremia
and to control ﬂuid balance, high mortality rates continue in
patients with both AKI and ALI [22]. In progressive ALI and
ARDS, impaired global oxygenation will necessarily decrease
renal oxygenation leading to a vicious cycle of progressive
lung and kidney injury [23]. The crosstalk between the kid-
ney and the lung in the critically ill patient is of extreme
importance to all critical care physicians [4].
4. AKI andALI
The impact of AKI on the lung can be seen on many levels.
One of the major eﬀects of AKI is to eﬀect lung water
balance. While ﬂuid overload from anuric or oliguric AKI
can upset the hydrostatic-oncotic balance in the pulmonary
interstitium, inﬂammation and endothelial injury which
may be triggered by AKI also upset this equilibrium. The
contributions of the latter, inﬂammation, changes in expres-
sion of regulators of the pulmonary ﬂuid and electrolyte
chemical gradient, and altered regulation of oxidative stress,
may be greater than previously appreciated.
AKI triggers gene expression changes which may alter
lung vascular stability. Global gene expression mapping of
lung tissues in experimental murine kidney ischemia iden-
tiﬁes proinﬂammatory and proapoptotic gene upregulation
in the lung transcriptome [24]. Proinﬂammatory genes
such as Cd14, lipocalin-2, chemokine ligand-2 (CXCL2),
and IL-6 are all upregulated after ischemia [24]. These
mediators, notably IL-6, trigger acute phase responses to
antigens and initiate the inﬂammatory cascade. Subsequent
injury is caused by many mechanisms including: disruption
of endothelial integrity, aberrant signaling of the coagula-
tion and contact cascades, and direct cellular toxicity in
vital organs. Reduction of the IL-6 eﬀect using chemical
inhibition of IL-6 or use of IL-6-deﬁcient mice reduces
lung inﬂammation after ischemic AKI [25]. Caspase-3, a
marker of cellular apoptotic activity, is upregulated in type
II pneumocytes after experimental AKI [26]. Macrophages,
mediators of global injury and repair, may be involved; use
of macrophage activation inhibitor decreases the amount of
pulmonarycapillaryleakageinmurineischemia[27].Uremia
may contribute to such upregulation, as lung inﬂammation
and apoptosis are abrogated after nephrectomy [28]. In
repeated animal models of AKI, proinﬂammatory mediators
are expressed within hours of injury. Circulating inﬂamma-
tory cytokines may aﬀect lung capillary endothelium, chang-
ing permeability. Apoptosis of either capillary endothelial
cells or pneumocytes responsible for producing surfactant
will also change the permeability of the interstitial-alveolar
interface in the lung. Cytokine, chemokine, and apoptotic
dysregulation is therefore a prime suspect of ALI after AKI
and demonstrates kidney-lung crosstalk.
Fluid and electrolyte conduction in the lung is altered in
AKI. Rabb and colleagues published the seminal work des-
cribing the downregulation of pulmonary ENaC, Na/K
ATPase, and aquaporin-5 after ischemic injury and nephrec-
tomyinrats[29].Astheprimaryinterstitialsolute,sodiumis
the central determinant of ﬂuid shift based on osmolar gra-
dients. Changes in sodium balance on either side of the
capillary membrane, therefore, may have marked eﬀects on
ﬂuid shifts between the interstitium and the alveolar bed.
Aquaporin-1 message upregulation, in a sheep model of car-
diopulmonary bypass and hypothermic circulatory arrest,
was correlated with increased rates of pulmonary edema
[30]. Similarly, aquaporin-5 has been identiﬁed in sepsis as a
contributor to dysregulation in tissue and vascular permea-
bility [31]. In experimental models, osmotically driven water
permeability between the alveolar and capillary components4 Pulmonary Medicine
of the lung is changed tenfold by deletion of aquaporin-1
or aquaporin-5 [32]. While changes in aquaporin expression
may have only minor clinical ramiﬁcation, the evidence
for kidney-lung crosstalk is robust [33]. Aberrant salt and
water handling by the lung is altered in even mild models
of experimental kidney ischemia. The impact of this on
pulmonary edema formation is obvious.
Oxidative stress plays a role in the kidney-lung crosstalk
seen during AKI. Hepatic levels of superoxide dismutase,
glutathione, and catalase are decreased after ischemic AKI
in mice, which may decrease host response to oxidative
stress [34]. Additionally, TNF-α levels were signiﬁcantly
higher in ischemic mice than in sham controls pointing to a
systemic oxidative/inﬂammatory response of AKI [35]. The
nitric oxide signaling pathway is critical to oxidative balance
and is altered in AKI. Patients with chronic kidney disease
have lower basal production of nitric oxide compared to
controls, and mice subjected to subtotal nephrectomy have
lower levels of nitric oxide synthase [36, 37]. Finally, mice
lacking heme-oxygenase-1 (HO-1), critical for reducing
oxidative stress and generation of antioxidant metabolites,
have increased levels of inﬂammation after ischemic AKI
versus sham controls [38]. Nitric oxide, HO-1, and TNF-α
all aﬀect lung capillary stability [39–41]. Therefore, the
alteration in these regulators of oxidative balance after AKI
can aﬀect lung vascular stability.
The conclusion that signiﬁcant lung pathology results
from ischemic AKI models must be tempered by the fact
that, in practice, renal hypoperfusion without concurrent
pulmonary hypoperfusion is rare. Indeed, it is rarely known
if ischemia to the kidney occurs before or after ischemia to
the lungs. Models of hemorrhagic and septic shock do not
adequately address this issue. Additionally, in the common
case of decreased renal preload (i.e., prerenal azotemia),
the microscopic eﬀects on the lung have not been clearly
described. Still, the ﬁndings described above highlight the
potential contribution of the injured renal endothelium to
lung injury and edema formation.
5. Nephrogenic Pulmonary Edema
In the context of ischemic AKI and kidney-lung crosstalk,
we propose the concept of nephrogenic pulmonary edema.
Resting on the evidence of experimental extrarenal eﬀects of
AKI and the acknowledged clinical eﬀects of oliguric volume
overload, nephrogenic pulmonary edema (NPE) could rep-
resent net aberrant ﬂuid handling at the interstitial-alveolar
lung interface. On a microscopic level, NPE could result
as a consequence of damage of pulmonary endothelium
by AKI-mediated upregulated inﬂammation, disruption of
pulmonary sodium transport, and activation of apoptosis in
pulmonarycellsresponsibleformaintainingthehomeostatic
integrity of lung water balance. AKI should be counted
amongst the numerous disease processes that alter both
the volume load in the pulmonary capillary bed and the
endothelial integrity of the alveolar capillary barrier.
Experimental manifestations of kidney injury are mani-
fest in multiple extrarenal locations [42]. Experimental AKI
hasdeleteriouseﬀectsonthecentralnervoussystemaﬀecting
glial cell viability, blood-brain barrier permeability, and
neurocognitive status [43]. Systolic ventricular function is
negatively aﬀected by ischemic kidney injury [44]. Leukocyte
traﬃcking is aberrant, and a host of proinﬂammatory
genomic and proteomic responses occur after experimental
AKI [24, 45]. The experimental evidence for lung injury after
A K Ii sr o b u s t[ 4].
Critically ill patients with acute lung injury with AKI
have worse morbidity and mortality. Fluid overload and
uremia may be regulated by extracorporeal therapy such as
dialysis, but lung injury and kidney injury are progressive
and mortality rates in patients with both disease processes
have not signiﬁcantly improved with these therapies. Use
of stratiﬁcation criteria has retrospectively demonstrated
improved outcomes for patients with less severe AKI [46];
biomarker research seeks to identify kidney injury in its early
stages. Appreciation of the impact of kidney injury during
this epoch, before the onset of oliguria and ﬂuid overload,
may be critical. The impact of kidney-lung crosstalk on the
molecular level may be creating a milieu of lung inﬂam-
mation, mediated by proinﬂammatory, oxidative, chemical,
and apoptotic signals. Ultimately, the accumulated signals
overpower the ability of the lung to regulate ﬂuid balance,
leading to nephrogenic pulmonary edema.
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